openPR Logo
Press release

BII announces Admission Notice for forthcoming session of “Advance Program in Clinical Trials”

10-02-2008 01:45 PM CET | Science & Education

Press release from: Bioinformatics Institute of India

Bioinformatics Institute of India announces Admission notice for its next batch of weekend “Advance Program in Clinical Trial, Research and Data management”. This weekend program is of 6 months duration and will commence from 15th December’08 at BII Noida.

The ongoing batch of the program is quite successful and is pursued by many doctors, medical professionals, B.Pharma, B.Sc & other science graduates. The classes are taken up by experienced faculty from industry and academia at Institute’s Noida centre on every Sunday. Students are also trained to work on “Open Clinica software” which is used in industry for Clinical Data Management.

BII has announced the commencement of its forthcoming session from 15th December 2008, for which the registration is open now. Some of the salient features of the program are:

• 6 months weekend program

• Guest lecture from industry and academia

• Open Clinica software

• e-learning opportunity

• Research study

• Clinical site visits etc.

To register in the above mentioned program Kindly download the registration form from our website www.bii.in. You can also call us to solve any further query and can speak with our academic counselor. Last date for registration is 30th November’08

Career opportunities
According to McKinsey report, by 2010 more than 50,000 professionals will be required in the field of clinical research in India alone. This means science, pharmacy and medicine graduates can look forward to exciting and rewarding career opportunities in clinical research.

Placement Support is provided

Established in 2002 Bioinformatics Institute of India (BII) is a reputed and globally recognised institution for imparting quality education and training in the emerging disciplines of Bioinformatics, Clinical Trials, Pharma Regulatory affairs, Pharma Quality Assurance and Control, Drug Design and Patenting, IPR and Biotechnology etc.

Working professionals from hundreds of reputed companies and students from elite institutes have participated and benefitted from our programs. BII is proud to have participants from more than 40 countries in these programs

For Further details contact:
Bioinformatics Institute of India
C-56A/28, Sector - 62
Noida - 201301, U.P
Tel: 0120-4320801/02
9818473366, 9810535368
Visit: www.bii.in
Email: info@bii.in

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release BII announces Admission Notice for forthcoming session of “Advance Program in Clinical Trials” here

News-ID: 55489 • Views:

More Releases from Bioinformatics Institute of India

BII announces its Corporate Trainings for 2008
Bioinformatics Institute of India has announced various Corporate Trainings for the year 2008. The training areas have been identified after assessment of current industry requirements. BII offers training solutions designed specifically to meet the needs of the corporate clients .The objective of these trainings is to enable world-class companies increase productivity and performance through their people. BII is ready to provide training in the following areas • Biostatistics and Hospital Data Analysis • Application
Admission open in BII Noida for Autumn 2007 Batch
Bioinformatics Institute of India, has been setup as a premier Bioinformatics society, for the promotion, growth and prosperity of bioinformatics sciences. The institute has been promoted as a non profit making educational, R&D and development centre of bioinformatics. The aim and vision of the institute is to provide a platform for individuals, professionals, R&D Organisations, Pharmaceutical & Software companies to utilize and harness the Indian bioinformatics potential. BII is the pioneer

More Releases for Clinica

Clinical Trial Management System CTMS Market to hit US$ 2478.15 million, Globall …
Global clinical trial management system (CTMS) market was valued at US$ 727.54 million in 2021 and is expected to reach US$ 2478.15 million by 2030, growing at an estimated CAGR of 14.6% over the forecast period. A New Market study by Absolute Markets Insights on the Global Clinical Trial Management System CTMS Market Report offers an in-house analysis of global economic conditions and related economic factors and indicators to evaluate their
Clinical Trial Management System Market Projection 2025 | Bio Clinica, Medidata …
Clinical Trial Management System Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges. Constant need for conducting clinical trials and growing expenditures on clinical studies will stir the demand for clinical trial management systems (CTMS) in the coming years.
Global Big Data Analytics in Healthcare Market, by Analytics type (Descriptive A …
Global Big Data Analytics in Healthcare Market was valued at US$ 23.93 million in 2019 and is projected to reach US$ 81.35 million by 2025, at a CAGR of 19.1% during the forecast period. A surge in the demand for analytics solutions for citizen health management, increase in the adoption of cloud analytics among several end users, growing need for business intelligence to optimize health administration & strategy, lack of
Clinical Trial Management System Market Top Companies - Bio Clinica Inc., Bio-O …
Clinical Trial Management System Market will exceed USD 2.5 billion by 2025; as per a new research report. Increasing demand for contract research organizations for conducting clinical trials will augment the clinical trial management systems business growth over the analysis period. Benefits associated with outsourcing clinical trials including on time delivery, reduced cycle times and decreased administrative costs will foster industry growth. Use of clinical trials management systems (CTMS) in
Healthcare Services Market by Profiling Key Players AAC Holdings, Abano Healthca …
The global healthcare services Market reached a value of nearly $6,707.3 billion in 2018, having grown at a compound annual growth rate (CAGR) of +7.6% since 2014, and is expected to grow at a CAGR of +9.3% to nearly $9,581 billion by 2025. The healthcare market is growing rapidly and offers new opportunities and risks for companies in this sector and those operating in the broader healthcare value chain. Together with
(CTMS) Clinical Trial Management System Market Analysis Focusing on Top Key Play …
CTMS Market size is set to exceed USD 2.5 billion by 2025; according to a new research report by Global Market Insights. Increasing clinical trials worldwide is the key factor that will augment the global CTMS market growth during the forecast period. Initiatives by government organizations such as NIH to conduct various clinical studies for detection and prevention of diseases will favor segment growth. Moreover, presence of regulatory bodies to enforce